Concourse Financial Group Securities, Inc. Revolution Medicines, Inc. Transaction History
Concourse Financial Group Securities, Inc.
- $1.67 Billion
- Q4 2024
Number of Shares
0
Previous 0
NaN%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding RVMD
# of Institutions
299Shares Held
171MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$680 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$534 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$527 Million3.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$377 Million0.22% of portfolio
-
Baker Bros. Advisors LP New York, NY7.94MShares$316 Million3.85% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.49B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...